Close Menu

Insight Genetics' Insight RET Screen

Insight Genetics has launched Insight RET Screen, a CLIA-validated assay that detects oncogenic RET (rearranged during transfection) expression in non-small cell lung cancer (NSCLC) patients.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Newsweek discusses the privacy issues raised by digital medicine.

A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.

In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.